Literature DB >> 6494500

Toxicological screening.

G Zbinden, J Elsner, U A Boelsterli.   

Abstract

Well-defined dose- and time-related toxic effects of chemicals can often be detected using simple tests with small numbers of animals. The strategies for the establishment of toxicological screening tests are discussed. The most important steps are the definition of the targets, the selection of the methods, and the setting of the test criteria. Screening tests must then be validated with standard reference chemicals, and the test criteria must be adjusted so that the standards can be detected regularly. Maximal flexibility is allowed in the design of the tests. For evaluation, the results obtained in treated animals can be compared with those of controls, using conventional concepts of biostatistics. It is also possible to base the evaluation on preset test criteria. Toxicological screening tests do not replace conventional safety studies, but they help in selecting the most promising candidates in a series of related chemicals and in establishing priorities for further testing. As an example, a screening for the hemolytic effects of chemicals is presented.

Mesh:

Year:  1984        PMID: 6494500     DOI: 10.1016/0273-2300(84)90027-8

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  4 in total

Review 1.  Animal models.

Authors:  G L Plaa
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

Review 2.  Invited contribution: acute toxicity testing, public responsibility and scientific challenges.

Authors:  G Zbinden
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

3.  Nephrotoxicity screening in rats; general approach and establishment of test criteria.

Authors:  G Zbinden; K Fent; M H Thouin
Journal:  Arch Toxicol       Date:  1988-04       Impact factor: 5.153

4.  Nephrotoxicity screening in rats: a validation study.

Authors:  K Fent; E Mayer; G Zbinden
Journal:  Arch Toxicol       Date:  1988-04       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.